Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
Recruiting · NCT06617897 · Registry updated 2026-03-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, adenocarcinoma, blood coagulation disease, carcinoma, coagulation protein disease, congenital afibrinogenemia, cystic, mucinous, and serous neoplasm, epithelial neoplasm, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Phase 3 | 2026-03-11 | NCT06617897 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CSL Behring | 25 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Basingstoke and North Hampshire Hospital | Basingstoke | United Kingdom | 7 |